Get started
Author

Moisés Garcı́a-Arencibia

Observed names: García-Arencibia, Moisés, M Garcia-Arencibia, M García-Arencibia, M García‐Arencibia, M. Garcia-Arencibia, M. García-Arencibia, Moises Garcia Arencibia, Moises Garcia-Arencibia, Moises Garcia‐Arencibia, Moisés García-Arencibia, Moisés García-Arencíbia, Moisés García-arencibia
Observed institutions: Universidad de Las Palmas de Gran Canaria, Universidad Complutense de Madrid, University of Cambridge, Instituto de Salud Carlos III, Biomedical Research Networking Center on Neurodegenerative Diseases, Gobierno de Canarias, Centro de Investigación Biomédica en Red, Instituto Ramón y Cajal de Investigación Sanitaria, Addenbrooke's Hospital, Wellcome Trust
ORCID: 0000-0002-1618-4487
Observed ORCID: 0000-0002-1618-4487
OpenAlex ID: A5068058486
TFEB Links Autophagy to Lysosomal Biogenesis
2011 · Carmine Settembre, Chiara Di Malta, et al. · Science · 3,335
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 · Brinda Ravikumar, Sovan Sarkar, et al. · Physiological Reviews · 1,727
PDF
Complex Inhibitory Effects of Nitric Oxide on Autophagy
2011 · Sovan Sarkar, Viktor I. Korolchuk, et al. · Molecular Cell · 383
PDF
Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration
2009 · Suzana Gispert, Filomena Ricciardi, et al. · PLoS ONE · 381
PDF
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
2006 · Moisés García-Arencibia, Sara González, et al. · Brain Research · 320
Symptom‐relieving and neuroprotective effects of the phytocannabinoid Δ 9 ‐THCV in animal models of Parkinson's disease
2011 · C García, C Palomo‐Garo, et al. · British Journal of Pharmacology · 211
Bim Inhibits Autophagy by Recruiting Beclin 1 to Microtubules
2012 · Shouqing Luo, Moises Garcia-Arencibia, et al. · Molecular Cell · 203
PDF
Autophagy, a guardian against neurodegeneration
2010 · Moisés García-Arencibia, Warren E. Hochfeld, et al. · Seminars in Cell and Developmental Biology · 158
PDF
Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease
2010 · B. R. Underwood, S. Imarisio, et al. · Human Molecular Genetics · 155
PDF
Identification of MOAG-4/SERF as a Regulator of Age-Related Proteotoxicity
2010 · Tjakko J. van Ham, Mats A. Holmberg, et al. · Cell · 140
PDF
Autophagy and misfolded proteins in neurodegeneration
2010 · Daniel J. Metcalf, Moisés García-Arencibia, et al. · Experimental Neurology · 139
PDF
A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice
2010 · Alexander Kurz, Kay L. Double, et al. · PLoS ONE · 137
PDF
Role of CB2 receptors in neuroprotective effects of cannabinoids
2008 · Javier Fernández-Ruiz, María Ruth Pazos, et al. · Molecular and Cellular Endocrinology · 125
Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease
2006 · Sara González, Camila Scorticati, et al. · Brain Research · 118
Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity
2014 · F M Menzies, M Garcia-Arencibia, et al. · Cell Death and Differentiation · 117
PDF
Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats
2008 · Consuelo Calle, Begoña Maestro, et al. · BMC Molecular Biology · 107
PDF
Cannabinoids and Neuroprotection in Basal Ganglia Disorders
2007 · Onintza Sagredo, Moisés García-Arencibia, et al. · Molecular Neurobiology · 103
IGF-1 receptor antagonism inhibits autophagy
2013 · Maurizio Renna, Carla F. Bento, et al. · Human Molecular Genetics · 89
PDF
Cannabinoids and Parkinsons Disease
2009 · Moises Garcia-Arencibia, Concepcion Garcia, et al. · CNS & Neurological Disorders - Drug Targets · 69
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor
2018 · Concepción García, María Gómez-Cañas, et al. · Journal of Neuroinflammation · 65
PDF
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease
2013 · Pedro González-Naranjo, Natalia Pérez-Macias, et al. · European Journal of Medicinal Chemistry · 51
Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson’s Disease
2013 · M.A. del Rio, M.I. Sanchez-Reus, et al. · CNS & Neurological Disorders - Drug Targets · 49
Cannabinoid CB1 Receptors are Early DownRegulated Followed by a Further UpRegulation in the Basal Ganglia of Mice with Deletion of Specific Park Genes
2009 · Moisés García-Arencibia, Concepción García, et al. · Springer eBooks · 48
Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells
2018 · Moises Garcia‐Arencibia, Eduardo Molina-Holgado, et al. · British Journal of Pharmacology · 43
PDF
Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats
2008 · Moisés García-Arencibia, Luca Ferraro, et al. · Neuroscience Letters · 43
Works count: 52
Citation count: 8,497
H-index: 27
I10-index: 32
Year
Topic
Type